Form 3 - Initial statement of beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Ardelyx Charts.

Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Ardelyx Charts.

Ardelyx Inc News

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025
Thursday 30 January 2025 (3 days ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Thursday 16 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
Monday 13 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Monday 6 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
Wednesday 20 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 18 November 2024 (2 months ago) • Edgar (US Regulatory)

More Ardelyx Inc News Articles

VanEck Pharmaceuticals ETF

Fundo Investimento Imobi...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions